10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 87 filers reported holding 10X GENOMICS INC in Q4 2019. The put-call ratio across all filers is 0.41 and the average weighting 2.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $589,174 | -93.8% | 14,283 | -91.7% | 0.01% | -94.7% |
| Q2 2023 | $9,552,660 | +410943.9% | 171,072 | +310.7% | 0.11% | +216.7% |
| Q1 2023 | $2,324 | +78.9% | 41,655 | +16.9% | 0.04% | +38.5% |
| Q4 2022 | $1,299 | -100.0% | 35,647 | -57.1% | 0.03% | -73.7% |
| Q2 2022 | $3,756,000 | +24.0% | 82,997 | +108.4% | 0.10% | +39.4% |
| Q1 2022 | $3,030,000 | +518.4% | 39,832 | +1493.3% | 0.07% | +688.9% |
| Q2 2021 | $490,000 | -32.4% | 2,500 | -51.2% | 0.01% | -55.0% |
| Q4 2020 | $725,000 | -88.7% | 5,122 | -90.0% | 0.02% | -92.8% |
| Q3 2020 | $6,396,000 | +1016.2% | 51,296 | +351.2% | 0.28% | +1290.0% |
| Q3 2019 | $573,000 | – | 11,368 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |